Lean Toward Eliquis for the Best Balance of Efficacy and Safety in Atrial Fib

June 2018

Patients will ask you which anticoagulant is preferred to prevent stroke in atrial fibrillation.

Direct oral anticoagulants (DOACs), such as Eliquis (apixaban), are stepping ahead of warfarin in many atrial fib patients.

That's because DOACs prevent stroke at least as well as warfarin...cause slightly less intracranial bleeding...have fewer interactions...and don't need frequent monitoring.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Anticoagulants Lean Toward Eliquis for the Best Balance of Efficacy and Safety in Atrial Fib
Asthma Consider Tiotropium or Biologics for Severe Asthma
Diabetes Don't Advise Routine Glucose Monitoring if Results Won't Be Used
Depression Stay Alert for Depression in Teens
Naloxone Co-Prescribe Naloxone for Patients at Opioid Overdose Risk
Practice Use These Tips to Determine Whether Marketing Is Just Hype
Epinephrine Be Prepared for New Epinephrine Auto-Injector Barriers and Options
Toxicology Expect Large Vitamin K Doses for Bleeding Due to Laced Synthetic Cannabinoids
OTC Products Don't Jump to Lumify to Relieve Red Eyes
HIV & AIDS Be Ready for the New Combo HIV Med Biktarvy
Nebulizers Be Aware of Differences Between Lonhala Magnair and Other Nebulizers
Antithrombotics Think of Antiplatelets for Arterial Clots and Anticoagulants for Venous Clots
Antithrombotics Know When to Hold Antithrombotics Around Regional Anesthesia
Infectious Diseases Stay Alert for a New, Concentrated Rabies Immune Globulin Option